The role of radiotherapy in urinary bladder cancer: current status
- PMID: 22555038
- DOI: 10.1590/s1677-55382012000200002
The role of radiotherapy in urinary bladder cancer: current status
Abstract
The role of radiotherapy (RT) in the treatment of urinary bladder cancer has undergone several modifications along the last decades. In the beginning, definitive RT was used as treatment in an attempt to preserve the urinary bladder; however, the results were poor compared to those of radical surgery. Recently, many protocols have been developed supporting the use of multi-modality therapy, and the concept of organ preservation began to be reconsidered. Although phase III randomized clinical studies comparing radical cystectomy with bladder preservation therapies do not exist, the conservative treatment may present low toxicity and high indexes of complete response for selected patients. The aim of this study was to review the literature on the subject in order to situate RT in the current treatment of urinary bladder cancer.
Similar articles
-
Preoperative irradiation with and without chemotherapy as adjunct to radical cystectomy.Urology. 1985 Feb;25(2):127-34. doi: 10.1016/0090-4295(85)90527-8. Urology. 1985. PMID: 3918371 Clinical Trial.
-
Conservative treatment of invasive bladder carcinoma by transurethral resection, protracted intravenous infusion chemotherapy, and hyperfractionated radiotherapy: long term results.Cancer. 2004 Dec 1;101(11):2540-8. doi: 10.1002/cncr.20654. Cancer. 2004. PMID: 15481058 Clinical Trial.
-
Chemoradiotherapy as a bladder-preservation approach for muscle-invasive bladder cancer: current status and perspectives.Int J Clin Oncol. 2004 Dec;9(6):484-90. doi: 10.1007/s10147-004-0434-0. Int J Clin Oncol. 2004. PMID: 15616879 Review.
-
[Chemoradiation in bladder cancer].Bull Cancer. 2005 Dec;92(12):1073-7. Bull Cancer. 2005. PMID: 16396753 Review. French.
-
[Concomitant chemoradiotherapy of infiltrating cancers of the bladder].Cancer Radiother. 1998 Dec;2(6):713-7. doi: 10.1016/s1278-3218(99)80013-4. Cancer Radiother. 1998. PMID: 9922778 Review. French.
Cited by
-
High expression of TMEM40 is associated with the malignant behavior and tumorigenesis in bladder cancer.J Transl Med. 2018 Jan 19;16(1):9. doi: 10.1186/s12967-017-1377-3. J Transl Med. 2018. PMID: 29351801 Free PMC article.
-
Radiotherapy in muscle-invasive bladder cancer: the latest research progress and clinical application.Am J Cancer Res. 2015 Jan 15;5(2):854-68. eCollection 2015. Am J Cancer Res. 2015. PMID: 25973322 Free PMC article.
-
Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.Oncotarget. 2017 Apr 11;8(15):24202-24212. doi: 10.18632/oncotarget.15527. Oncotarget. 2017. PMID: 28445936 Free PMC article.
-
Synthetic Bax-Anti Bcl2 combination module actuated by super artificial hTERT promoter selectively inhibits malignant phenotypes of bladder cancer.J Exp Clin Cancer Res. 2016 Jan 8;35:3. doi: 10.1186/s13046-015-0279-6. J Exp Clin Cancer Res. 2016. PMID: 26743236 Free PMC article.
-
Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.Oncotarget. 2015 Dec 1;6(38):41194-203. doi: 10.18632/oncotarget.5880. Oncotarget. 2015. PMID: 26517688 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical